Notably, in acute myeloid leukemia (AML), CEBPz was shown to promote the m6A modification of target mRNA transcripts, enhancing their translation (Barbieri et al., 2017; Hong et al., 2022). Here, CEBPZ is linked to acute myeloid leukemia.